{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:23Z","timestamp":1788922223787,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpeds.2025.114725","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:58:00Z","timestamp":1752767880000},"page":"114725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Opioid-Related Pharmacogenomic Variants in a Retrospective Cohort of High-Risk Hospitalized Infants"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4158-3571","authenticated-orcid":false,"given":"Rabab M.","family":"Barq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadassa","family":"Ourshalimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Maggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Deardorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamorah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Mosley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine I.","family":"Kelley-Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2025.114725_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41372-022-01332-6","article-title":"Iatrogenic opioid withdrawal in hospitalized infants","volume":"42","author":"Kelley-Quon","year":"2022","journal-title":"J Perinatol"},{"key":"10.1016\/j.jpeds.2025.114725_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5055\/jom.2015.0279","article-title":"Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal HHS public access","volume":"11","author":"Lewis","year":"2015","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpeds.2025.114725_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2023.18910","article-title":"Opioid and methadone use for infants with surgically treated necrotizing enterocolitis","volume":"6","author":"Keane","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2025.114725_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jss.2024.07.028","article-title":"The cost of opioid use in high-risk hospitalized infants","volume":"302","author":"Keane","year":"2024","journal-title":"J Surg Res"},{"key":"10.1016\/j.jpeds.2025.114725_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jpeds.2015.12.024","article-title":"Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine","volume":"172","author":"Zwicker","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2025.114725_bib6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.pain.2011.02.017","article-title":"Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: five-year follow-up of a randomized controlled trial","volume":"152","author":"De Graaf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpeds.2025.114725_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2015.11.001","article-title":"Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2 years","volume":"92","author":"Kocek","year":"2016","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jpeds.2025.114725_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jpeds.2015.02.012","article-title":"Neonatal morphine exposure in very preterm infants-cerebral development and outcomes HHS public access","volume":"166","author":"Steinhorn","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2025.114725_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0555","article-title":"Institutional and regional variation in opioid prescribing for hospitalized infants in the US","volume":"7","author":"Keane","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2025.114725_bib10","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1097\/PCC.0000000000002873","article-title":"2022 Society of Critical Care Medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility","volume":"23","author":"Smith","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jpeds.2025.114725_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","article-title":"Pharmacogenomics","volume":"394","author":"Roden","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2025.114725_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/ALN.0000000000004677","article-title":"Association of Genetic Variants with postsurgical pain: a systematic review and meta-analyses","volume":"139","author":"Frangakis","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpeds.2025.114725_bib13","article-title":"Genetic associations of persistent opioid use after surgery: a hypothesis-driven analysis of high-value genetic variants in the Michigan genomics initiative dataset","author":"Brummett","year":"2023","journal-title":"Res Square"},{"key":"10.1016\/j.jpeds.2025.114725_bib14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11864-022-01010-x","article-title":"The role of pharmacogenomics in opioid prescribing","volume":"23","author":"Wong","year":"2022","journal-title":"Options Oncol"},{"key":"10.1016\/j.jpeds.2025.114725_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1099800416680474","article-title":"OPRM1 and COMT gene-gene interaction is associated with postoperative pain and opioid consumption after orthopedic trauma","volume":"19","author":"Khalil","year":"2017","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.jpeds.2025.114725_bib16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1213\/ANE.0000000000000411","article-title":"Catechol-O-Methyltransferase polymorphisms predict opioid consumption in postoperative pain","volume":"119","author":"Candiotti","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpeds.2025.114725_bib17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jpain.2016.02.003","article-title":"Human genetic variability contributes to postoperative morphine consumption","volume":"17","author":"De Gregori","year":"2016","journal-title":"J Pain"},{"key":"10.1016\/j.jpeds.2025.114725_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/tpj.2014.59","article-title":"Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents","volume":"15","author":"Chidambaran","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jpeds.2025.114725_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11096-009-9349-1","article-title":"CYP2D6 4, CYP3A5 3 and ABCB1 3435T polymorphisms and drug-related falls in elderly people","volume":"32","author":"Blonk","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.jpeds.2025.114725_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/phar.2768","article-title":"A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults","volume":"43","author":"Dzierba","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpeds.2025.114725_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jpeds.2025.114725_bib22","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1002\/jcph.1891","article-title":"Pharmacogenomics for drug dosing in children: current use, knowledge, and gaps","volume":"61","author":"Hoshitsuki","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2025.114725_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/009286159603000429","article-title":"Introduction: drug development for infants and children: Rescuing the therapeutic Orphan","volume":"30","author":"Kearns","year":"1996","journal-title":"Drug Inf J"},{"key":"10.1016\/j.jpeds.2025.114725_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004\u20132011","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatology"},{"key":"10.1016\/j.jpeds.2025.114725_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jpeds.2025.114725_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/j.1532-2149.2012.00153.x","article-title":"Pain sensitivity in fibromyalgia is associated with catechol-O- methyltransferase (COMT) gene","volume":"17","author":"Mart\u00ednez-Jauand","year":"2013","journal-title":"Eur J Pain (UK)"},{"key":"10.1016\/j.jpeds.2025.114725_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humimm.2014.12.005","article-title":"Association between DRD2\/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis","volume":"76","author":"Deng","year":"2015","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jpeds.2025.114725_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bcpt.12248","article-title":"Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption","volume":"115","author":"Bastami","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jpeds.2025.114725_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075359","article-title":"Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study","volume":"8","author":"Beer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2025.114725_bib31","first-page":"331","article-title":"The relevance of the OPRM1 118A>G genetic variant for opioid requirement in pain treatment: a meta-analysis","volume":"22","author":"Zhang","year":"2019","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpeds.2025.114725_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38983-0","article-title":"Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma","volume":"13","author":"Mang\u00f3","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpeds.2025.114725_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/pme-2017-0032","article-title":"Clinical application of pharmacogenetics in pain management","volume":"15","author":"Max Smith","year":"2018","journal-title":"Per Med"},{"key":"10.1016\/j.jpeds.2025.114725_bib34","first-page":"111","article-title":"Pharmacogenetics: an important part of drug development with a focus on its application","volume":"1","author":"Oates","year":"2018","journal-title":"Int J Biomed Investig"},{"key":"10.1016\/j.jpeds.2025.114725_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/nar\/30.1.38","article-title":"The ensembl genome database project","volume":"30","author":"Hubbard","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpeds.2025.114725_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/cpt.1275","article-title":"The evolution of PharmVar","volume":"105","author":"Gaedigk","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cpt.910","article-title":"The Pharmacogene Variation (PharmVar) Consortium: incorporation of the human cytochrome P450 (CYP) allele nomenclature database","volume":"103","author":"Gaedigk","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib38","article-title":"ClinPharmSeq: a targeted sequencing panel for clinical pharmacogenetics implementation","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2025.114725_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73748-3","article-title":"Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences","volume":"14","author":"Sherman","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpeds.2025.114725_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/cpt.280","article-title":"Pharmacogenetic allele nomenclature: International Workgroup recommendations for test result reporting HHS public access author manuscript","volume":"99","author":"Kalman","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib41","doi-asserted-by":"crossref","first-page":"E611","DOI":"10.36076\/ppj.2018.6.E611","article-title":"Fundamental considerations for genetically-guided pain management with opioids based on CYP2D6 and OPRM1 polymorphisms","volume":"21","author":"Ruano","year":"2018","journal-title":"Pain Physician"},{"key":"10.1016\/j.jpeds.2025.114725_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cts.12692","article-title":"Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jpeds.2025.114725_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13073-020-00761-2","article-title":"Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches","volume":"12","author":"Pedersen","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jpeds.2025.114725_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/biomedicines12040729","article-title":"Pharmacogenetic approaches in personalized medicine for postoperative pain management","volume":"12","author":"Ferreira Do Couto","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpeds.2025.114725_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.10446","article-title":"Assessment of the implementation of pharmacogenomic testing in a pediatric tertiary care setting + invited commentary + supplemental content","volume":"4","author":"Cohn","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpeds.2025.114725_bib46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and Considerations for pain management","volume":"37","author":"Owusu Obeng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpeds.2025.114725_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jpeds.2025.114725_bib48","doi-asserted-by":"crossref","DOI":"10.1590\/1678-7757-2023-0229","article-title":"Dental pain report in children and genetic polymorphism (rs4818) in Catechol-O-Methyltransferase (COMT) gene: a cross-sectional study","volume":"32","author":"Menoncin","year":"2024","journal-title":"J Appl Oral Sci"},{"key":"10.1016\/j.jpeds.2025.114725_bib49","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamapsychiatry.2020.1206","article-title":"Association of OPRM1 functional coding variant with opioid use disorder: a genome-wide association study","volume":"77","author":"Zhou","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpeds.2025.114725_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21003-y","article-title":"Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond","volume":"12","author":"Gaddis","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpeds.2025.114725_bib51","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/s41380-022-01709-1","article-title":"Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci","volume":"27","author":"Deak","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jpeds.2025.114725_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/jcpt.12585","article-title":"An analysis of genetic association in opioid dependence susceptibility","volume":"43","author":"Nagaya","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-055887","article-title":"Impact of the 2017 FDA drug safety communication on codeine and tramadol dispensing to children","volume":"150","author":"Renny","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2025.114725_bib55","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41436-018-0431-8","article-title":"CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial","volume":"21","author":"Smith","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2025.114725_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib57","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/cpt.3338","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2B6 genotype and methadone therapy","volume":"116","author":"Robinson","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpeds.2025.114725_bib54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003495-200868090-00004","article-title":"Necrotizing enterocolitis in newborns","volume":"68","author":"Thompson","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jpeds.2025.114725_bib58","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-022-05420-7","article-title":"Mono- and biallelic variant effects on disease at biobank scale","volume":"613","author":"Heyne","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jpeds.2025.114725_bib59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.gim.2021.12.009","article-title":"Clinical pharmacogenomic testing and reporting: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"24","author":"Tayeh","year":"2022","journal-title":"Genet Med"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625002665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347625002665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T08:32:37Z","timestamp":1764318757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347625002665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S0022347625002665"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114725","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid-Related Pharmacogenomic Variants in a Retrospective Cohort of High-Risk Hospitalized Infants","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2025.114725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114725"}}